RJ4287
/ Ruijie Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 06, 2023
Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=98 | Recruiting | Sponsor: Nanjing Ruijie Pharma Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
June 27, 2023
Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=98 | Not yet recruiting | Sponsor: Nanjing Ruijie Pharma Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1